| Stem Cells as Drugs: Responsibilities and Rules | Ethics |
| Regulations |
| Donors as Research Subjects | Clinical trials with unrelated donors - why |
| WMDA standpoint and practice / Clinical trials with unrelated donors - how |
| Cord Blood Banking | An obstetricians’ viewpoint |
| Public CB Banking: Processing and Quality |
| Public and Private CB Banks: Possible Partners? |
| Cord Blood Transplantation | Double Transplants |
| CB-Tx: can we still use only one CBU alone if cell counts are insufficient? |
| HLA | HLA Antibodies |
| Matching Probability |
| HLA and Minorities |
| Non hematopoietic Cells & Non-hematopoietic Use | Biology of Mesenchymal Stem cells |
| Use of Mesenchymal Stem cells |
| Somatic stem cell therapy - possibilities and obstacles |
| Donor Follow-up | The Swiss Follow-up System |